Publicacions en què col·labora amb Eva M. Carro Díaz (13)

2020

  1. Salivary lactoferrin as biomarker for Alzheimer's disease: Brain-immunity interactions

    Alzheimer's and Dementia, Vol. 16, Núm. 8, pp. 1196-1204

2019

  1. Neurological disorders in central Spain, second survey: Feasibility pilot observational study

    Journal of Medical Internet Research, Vol. 21, Núm. 1

2017

  1. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 8, pp. 131-138

2015

  1. Soluble megalin is reduced in cerebrospinal fluid samples of alzheimer’s disease patients

    Frontiers in Cellular Neuroscience, Vol. 9, Núm. APR

2011

  1. IGF-I gene variability is associated with an increased risk for AD

    Neurobiology of Aging, Vol. 32, Núm. 3, pp. 556.e3-556.e11

2010

  1. A megalin polymorphism associated with promoter activity and Alzheimer's disease risk

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 153, Núm. 4, pp. 895-902

  2. Aβ accumulation in choroid plexus is associated with mitochondrial-induced apoptosis

    Neurobiology of Aging, Vol. 31, Núm. 9, pp. 1569-1581

  3. Megalin interacts with APP and the intracellular adapter protein FE65 in neurons

    Molecular and Cellular Neuroscience, Vol. 45, Núm. 3, pp. 306-315

  4. PLA2G3, a gene involved in oxidative stress induced death, is associated with Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 22, Núm. 4, pp. 1181-1187

  5. Risk of incident dementia in drug-untreated arterial hypertension: A population-based study

    Journal of Alzheimer's Disease, Vol. 22, Núm. 3, pp. 949-958

  6. Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

    BMC neurology, Vol. 10, pp. 108

  7. The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease

    Biomaterials, Vol. 31, Núm. 21, pp. 5608-5618

2009

  1. Cytoplasmic gelsolin increases mitochondrial activity and reduces Aβ burden in a mouse model of Alzheimer's disease

    Neurobiology of Disease, Vol. 36, Núm. 1, pp. 42-50